{"pageContent": "Purpose: To gain knowledge about the factors associated with discontinuation of scheduled treatment in elderly men with castration-resistant prostate cancer (CRPC).", "metaData": {"source": "Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021\nhttps://pubmed.ncbi.nlm.nih.gov/34407909/"}}